Search

Memorial Sloan Kettering Cancer Center (MSK) announces the following awards and appointments:

… Thursday, July 28, 2022 Memorial Sloan Kettering Cancer Center (MSK) announces the following awards and appointments: Ya-Ting Wang and Inaki Etxberria Ya-Ting “Emma” Wang and Inaki Etxberria Receive Prestigious Early Career Researcher Awards Ya-Ting “Emma” Wang , postdoctoral fellow, was named the 2022

… Monday, December 27, 2021 Building on their long-term shared commitment to international collaboration on cancer research and care – Memorial Sloan Kettering Cancer Center (MSK) and the Chinese Thoracic Oncology Group (CTONG), an alliance of more than 30 premier academic cancer centers in China – joined

Learn how testicular cancer is often misunderstood and why it is highly treatable.

… Thursday, June 29, 2023 Highlights Testicular cancer Testicular cancer is a rare but very curable disease. Testicular cancer strikes younger men (people whose sex assigned at birth was male). An injury to your testicles (getting “hit in the balls”) does not cause testicular cancer.   Many people with

Read about a new treatment for people with some ER+, HER2- advanced breast cancers.

… Friday, December 12, 2025 Updated results from a clinical trial show that a new treatment continues to be effective at stopping advanced breast cancer from progressing in some people with tumors that have grown resistant to standard therapy. The new data also suggests that overall survival can be improved

What inspires the outstanding young scientists who come from around the world to train at MSK?

… Thursday, September 11, 2025 Their stories are all different — the daughter of farmers in rural China, the first scientist in a family of English professors, the child from a small town in Italy who never stopped asking “Why?” But one thing unites them: They left behind family and friends, their familiar

… Wednesday, September 28, 2022 Alexis Lopez is a self-described “MSK baby,” due to the 23-year career he’s built at Memorial Sloan Kettering Cancer Center (MSK), as well as the three decades his mother, Amarilis, served as a patient financial representative at MSK before retiring in 2014. “MSK has always

Memorial Sloan Kettering researchers say a drug that acts on noncancerous, tumor-infiltrating cells might provide a new treatment option for the most common and aggressive type of brain cancer.

… Tuesday, October 15, 2013 Summary Memorial Sloan Kettering researchers say a drug that acts on noncancerous, tumor-infiltrating cells might provide a new treatment option for the most common and aggressive type of brain cancer. White blood cells called macrophages patrol almost every tissue of the body

Learn how MSK researchers are trying to understand how the immune system senses cancer in order to make better immunotherapies.

… Friday, March 14, 2025 One way our immune system protects us is by ridding our bodies of altered cells that could lead to cancer. But exactly how and when does our immune system sense cancer? How do tumors evolve to avoid being detected? And how can a better understanding of this process help develop

Read about some of the most important clinical advances made at MSK in 2020.

… Monday, December 21, 2020 In 2020, Memorial Sloan Kettering clinical researchers continued to make major discoveries that will improve the treatment of cancer and guide the development of new therapies. Many of these studies were made possible by philanthropic donations, which allow researchers to pursue

Dr. Rudensky studies the development of white blood cells called T lymphocytes, which participate in the immune system response to infection. He joined the Sloan Kettering Institute in 2009.

… Wednesday, September 26, 2012 Summary Dr. Rudensky studies the development of white blood cells called T lymphocytes, which participate in the immune system response to infection. He joined the Sloan Kettering Institute in 2009. Alexander Y. Rudensky has been appointed the new Chair of the Immunology